Tscan Therapeutics Inc (TCRX): Eigentümerstruktur
Der letzte verfügbare Schlusskurs ist 27.07.2026. Die angezeigten Informationen beziehen sich auf den historischen Stand und sind nicht tagesaktuell.
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 6 US Dollar | 4 | 4 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 61.074.229 | 3,09 | 1,42 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Tscan Therapeutics Inc
Mitarbeiter 138
Handelsplatz NASDAQ
Ticker Symbol TCRX
IPO Datum 2021-07-16
Adresse 830 Winter Street, Waltham, MA, United States, 02451
Webseite https://www.tscan.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Gavin MacBeath Ph.D. | CEO & Director |
| 2 | Mr. Jason A. Amello CPA | CFO, Treasurer, Principal Financial Officer & Principal Accounting Officer |
| 3 | Dr. Chrystal U. Louis M.D., M.P.H. | Chief Medical Officer |
| 4 | Dr. Stephen J. Elledge Ph.D. | Co-Founder & Chairman of Scientific Advisory Board |
| 5 | Mr. Tomasz Kula Ph.D. | Co-Founder & Member of Advisory Board |
| 6 | Dr. Zoran Zdraveski J.D., Ph.D. | Chief Legal & Strategy Officer and Company Secretary |
| 7 | Ms. Ann Hargraves | Chief Human Resources Officer |
| 8 | Dr. Shrikanta Chattopadhyay M.D. | Senior VP & Head of Translational Medicine |
| 9 | Mr. Ray Lockard M.B.A. | Chief Manufacturing & Quality Officer |
| 10 | Mr. Jim Murray | Chief Development Operations Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Lynx1 Capital Management, LP | 12,27% | 6,37 Mio. USD |
| 2 | Bvf Inc | 8,51% | 4,42 Mio. USD |
| 3 | Baker Bros Advisors LP | 4,26% | 2,21 Mio. USD |
| 4 | Vanguard Group Inc | 3,79% | 1,97 Mio. USD |
| 5 | Vanguard Capital Management, LLC | 3,30% | 1,71 Mio. USD |
| 6 | BlackRock Inc | 2,82% | 1,46 Mio. USD |
| 7 | Millennium Management LLC | 2,23% | 1,16 Mio. USD |
| 8 | Renaissance Technologies Corp | 2,09% | 1,08 Mio. USD |
| 9 | Deer Management Co. LLC | 1,91% | 0,99 Mio. USD |
| 10 | Two Sigma Investments LLC | 1,85% | 0,96 Mio. USD |
| 11 | Aberdeen Group PLC | 1,40% | 0,73 Mio. USD |
| 12 | Jacobs Levy Equity Management, Inc. | 1,24% | 0,64 Mio. USD |
| 13 | DC Funds, LP | 0,96% | 0,50 Mio. USD |
| 14 | Geode Capital Management, LLC | 0,94% | 0,49 Mio. USD |
| 15 | GSA Capital Partners LLP | 0,58% | 0,30 Mio. USD |
| 16 | Two Sigma Advisers, LLC | 0,54% | 0,28 Mio. USD |
| 17 | D. E. Shaw & Co LP | 0,49% | 0,25 Mio. USD |
| 18 | Citadel Advisors Llc | 0,49% | 0,25 Mio. USD |
| 19 | Vanguard Fiduciary Trust Co | 0,47% | 0,24 Mio. USD |
| 20 | Marshall Wace Asset Management Ltd | 0,36% | 0,19 Mio. USD |